Story perspectives

Breakthrough Blood Test Detects Pancreatic Cancer with 92% Accuracy

2/3/2026

47 9

Center

Researchers Detect Cancer

Researchers from the University of Pennsylvania and Mayo Clinic developed a four-biomarker blood test, including ANPEP and PIGR, that detects pancreatic cancer with 92% accuracy across stages.
Pancreatic cancer has a 10% five-year survival rate, highlighting the need for larger population testing, especially for high-risk individuals.
Spanish scientists report eradicating pancreatic tumors in mice with a new triple-drug therapy, a finding that will require human trials.

Right

Researchers Eliminate Tumors

Spanish researchers report a triple therapy that completely eliminated pancreatic tumors in mice.
The therapy combines an experimental KRAS inhibitor, a protein degrader, and a lung cancer drug to prevent tumor resistance.
The study, published in the Proceedings of the National Academy of Sciences (PNAS), reported no major side effects.
Researchers caution that translating to human trials will be challenging and time-consuming, limiting near-term impact on prognosis.

1 of 2

Researchers Detect Cancer

Researchers from the University of Pennsylvania and Mayo Clinic developed a four-biomarker blood test, including ANPEP and PIGR, that detects pancreatic cancer with 92% accuracy across stages.
Pancreatic cancer has a 10% five-year survival rate, highlighting the need for larger population testing, especially for high-risk individuals.
Spanish scientists report eradicating pancreatic tumors in mice with a new triple-drug therapy, a finding that will require human trials.

1 / 2